The largest database of trusted experimental protocols

13 protocols using serum plus 2

1

Maintaining Primary Lymphatic Endothelial Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
For the experiment shown in Figures 1B, 1C, and S1A, primary lymphatic endothelial cells (LEC, PromoCell, adult female donor 419Z035.4) were maintained in Endothelial Cell Basal Medium MV2 supplemented with Growth Medium MV2 supplement pack (PromoCell) and used before passage 7. For small RNA-sequencing, subconfluent LEC (Lonza, adult female donor 5F1290) were harvested at passage 8. 293T/NoDice and 293T/DKO cells were maintained in Dulbecco modified Eagle medium (DMEM) containing 4.5 g/liter glucose and L-glutamine (Corning), supplemented with 10% Serum Plus-II (Sigma-Aldrich). The PEL cell lines BC-3 and BC-1 were maintained in RPMI 1640 medium containing L-glutamine (Corning), supplemented with 0.05mM b-mercaptoethanol (Sigma-Aldrich) and 20% Serum Plus-II (Sigma-Aldrich). The PEL cell lines BCBL-1 and JSC-1, as well as the KSHV-negative B cell line BJAB were maintained similarly but with 10% Serum Plus-II.
+ Open protocol
+ Expand
2

Cell Line Maintenance Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
HAP1 cells (male) were obtained from Horizons. NIH 3T3 (male) and HEK293FT (female) cells were obtained from ATCC. HAP1 cells were maintained at 37°C with 5% CO2 in I10 media: Iscove’s Modified Dulbecco’s Medium (Thermo Fisher) supplemented with 10% Serum Plus II (Sigma-Aldrich). NIH 3T3 cells were maintained at 37°C with 5% CO2 in D10 media: Dulbecco’s Modified Eagle’s Medium with high glucose and stabilized L-glutamine (Caisson Labs) supplemented with 10% Serum Plus II (Sigma-Aldrich). HEK293FT cells were maintained at 37°C with 5% CO2 in D10 media.
+ Open protocol
+ Expand
3

Cell Line Maintenance Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
HAP1 cells (male) were obtained from Horizons. NIH 3T3 (male) and HEK293FT (female) cells were obtained from ATCC. HAP1 cells were maintained at 37°C with 5% CO2 in I10 media: Iscove’s Modified Dulbecco’s Medium (Thermo Fisher) supplemented with 10% Serum Plus II (Sigma-Aldrich). NIH 3T3 cells were maintained at 37°C with 5% CO2 in D10 media: Dulbecco’s Modified Eagle’s Medium with high glucose and stabilized L-glutamine (Caisson Labs) supplemented with 10% Serum Plus II (Sigma-Aldrich). HEK293FT cells were maintained at 37°C with 5% CO2 in D10 media.
+ Open protocol
+ Expand
4

Maintaining Primary Lymphatic Endothelial Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
For the experiment shown in Figures 1B, 1C, and S1A, primary lymphatic endothelial cells (LEC, PromoCell, adult female donor 419Z035.4) were maintained in Endothelial Cell Basal Medium MV2 supplemented with Growth Medium MV2 supplement pack (PromoCell) and used before passage 7. For small RNA-sequencing, subconfluent LEC (Lonza, adult female donor 5F1290) were harvested at passage 8. 293T/NoDice and 293T/DKO cells were maintained in Dulbecco modified Eagle medium (DMEM) containing 4.5 g/liter glucose and L-glutamine (Corning), supplemented with 10% Serum Plus-II (Sigma-Aldrich). The PEL cell lines BC-3 and BC-1 were maintained in RPMI 1640 medium containing L-glutamine (Corning), supplemented with 0.05mM b-mercaptoethanol (Sigma-Aldrich) and 20% Serum Plus-II (Sigma-Aldrich). The PEL cell lines BCBL-1 and JSC-1, as well as the KSHV-negative B cell line BJAB were maintained similarly but with 10% Serum Plus-II.
+ Open protocol
+ Expand
5

Isolation and Differentiation of Bone Marrow-Derived Macrophages

Check if the same lab product or an alternative is used in the 5 most similar protocols
Bone marrow-derived macrophages (BMM) were isolated from femur exudates and differentiated at 37 °C in 5% CO2 in Dulbecco’s modified Eagle medium supplemented with 5 mM HEPES, 0.05 mM 2-mercaptoethanol, 100 U/mL penicillin/streptomycin, 10% Serum Plus II (Sigma) and containing 30% L929 conditioned medium for 7 days with additional medium added on day 3 or 4. L929 conditioned medium was generated using L929 cells (ATCC Cat no CCL-1, RRID:CVCL_0462) grown to confluency and incubated for 2 additional days before collecting the media. Differentiated BMM were collected by washing with ice-cold PBS containing 1 mM EDTA and resuspended in 10 mL supplemented antibiotic-free medium (without phenol red) containing 5% Serum Plus II and counted. Cells were diluted to 4*105 cells/mL and seeded using the following volumes: 100 μL/well: 96-well plate. 1 mL/well: 24-well plate. For 6-well plates and 6 cm petri dishes, 3–5*106 cells were seeded per well.
+ Open protocol
+ Expand
6

Engineered Cell Lines for Viral Research

Check if the same lab product or an alternative is used in the 5 most similar protocols
The HEK293FT cell line was obtained from Invitrogen and maintained in Dulbecco’s modified Eagle’s medium (Sigma, Cat#D5796-500ML) supplemented with 10% Serum Plus II (Sigma, Cat#14009C-500ML), 2 mM L-glutamine (VWR, Cat#02-0131-0100), 1 mM sodium pyruvate (Corning, Cat#25-000-CI), 10 mM nonessential amino acids (Lonza, Cat#13-114E), and 1% minimal essential medium vitamins (Sigma, Cat#M6895-100mL). The IPPK KO was derived from the HEK293FT cell line as previously described [17 (link)].
The proviral HIV plasmid construct consists of pNL4-3 HIV plus CMV-GFP in place of Nef (kindly obtained from Vineet KewalRamani). This HIV construct has Vif, Vpr and Env deleted and has several restriction sites silently added to the Gag gene for cloning purposes. EIAV proviral constructs consisted of the Gag/Pol expression vector pONY3.1 [40 (link)] and the GFP reporter vector pONY8.0G [43 (link)]. The K282A, Q350A, and K351A versions of pONY3.1 were made by standard cloning methods. The VSV-G construct consists of the coding sequence for VSV-g preceded by the EFa1 promoter [44 (link)] and obtained through the NIH AIDS Research and Reference Reagent Program.
+ Open protocol
+ Expand
7

Cell Culturing Techniques and Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
All cells were grown in an atmosphere of 5% carbon dioxide (CO2) at 37 °C. Unless indicated otherwise base media were supplemented with 10% heat-inactivated fetal bovine serum (Serum Plus II; Sigma-Aldrich) and 1% penicillin/streptomycin and L-Glutamine (Mediatech Inc.). Cells were dissociated with 0.25% (w/v) Trypsin—0.53 mM EDTA solution (Mediatech Inc.). 293T parental and Dicer knock out cells (clone 4–25, provided by Dr. Bryan Cullen, Duke University) (RRID:CVCL_0063) were cultured in DMEM (Cellgro). The HCT116 Ago 1/2/3 k.o. cells [53 (link)] were provided by David Corey (UT Southwestern). HCT116 Dicer k.o. cells were purchased from the Korean Collection for Type Cultures (KCTC, clone #43, cat #HC19023) and cultured in McCoy 5 A medium. Neuroblastoma cell line NB7 [54 (link)] was cultured in RPMI1640. Ago2 ko 293T cells (provided by Dr. Klaas Mulder, Radboud Institute for Molecular Life Sciences, Nijmegen, the Netherlands) and HeLa wt and Ago2 ko cells [55 (link)] (provided by Dr. Sarah Gallois-Montbrun, Université Paris Descartes, Paris, France), were all cultured in DMEM (Cellgro). Lipofectamine RNAiMAX was from ThermoFisher Scientific (#13778150).
+ Open protocol
+ Expand
8

Culturing Mammalian and Insect Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
HEK293T (ATCC), HeLa-LC3-GFP, and MEF (ATCC) cells were maintained in appropriate volume of Dulbecco’s Modified Eagle Medium supplemented with 10% serum (Serum Plus - II, Sigma), 100 units/mL penicillin and 100 units/mL streptomycin (Corning, VA). Schneider’s Drosophila Line 2 (S2 Schneider) was kindly provided by Henri Jasper, Buck Institute for Research for Aging. S2 cells were grown at 25 °C in Schneider’s Insect Medium (Himedia) that was prepared according to the manufacturer’s instructions.
+ Open protocol
+ Expand
9

Antiviral Compound Screening in Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
Stock solutions of ISL (Life Chemicals, Niagara-on-the-Lake, ON, Canada) and TDF (provided by AIDS Reagent Program) were prepared in distilled, deionized H2O. MT-2 cells [22 (link),23 (link)] were cultured in RPMI 1640 (Mediatech, Inc., Manassas, VA, USA), supplemented with 10% fetal bovine serum (FBS; HyClone, Logan, UT, USA) and 2 mM L-glutamine, 100 U/mL penicillin/streptomycin (Thermo Fisher, Waltham, MA, USA). (Mediatech, Inc., Manassas, VA, USA). HEK-293/17 [24 (link)] and TZM-GFP cells from Massimo Pizzato (Trento University, Trento Italy) cells were cultured in DMEM (Mediatech, Inc., Manassas, VA, USA) supplemented with 10% Serum Plus II (Sigma-Aldrich, St. Louis, MO, USA), 2 mM L-glutamine, and 100 U/mL penicillin/streptomycin.
+ Open protocol
+ Expand
10

Generation of Cas13d-expressing Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
HEK293FT cells were acquired from Thermo Fisher Scientific (R70007) and A375 cells were acquired from ATCC (CRL-1619). HEK293FT and A375 cells were maintained at 37°C with 5% CO2 in D10 media: DMEM with high glucose and stabilized L-glutamine (Caisson DML23) supplemented with 10% fetal bovine serum (Serum Plus II Sigma-Aldrich 14009C) and no antibiotics.
To generate doxycycline-inducible RfxCas13d-NLS HEK293FT and A375 cells, we transduced cells with a RfxCas13d-expressing lentivirus at low MOI (<0.1) and selected with 5μg/mL Blasticidin S (ThermoFisher A1113903). Single cell colonies were picked after by sparse plating. Clones were screened for Cas13d expression by western blot using mouse anti-FLAG M2 antibody (Sigma F1804).
For the GFP tiling screen RfxCas13d-expressing cells were transduced with pLentiEGFPdestabilized lentivirus at low MOI (<0.1) and selected with 100μg/ml Hygromycin B (ThermoFisher 10687010) for 2 days. Single-cell colonies were grown by sparse plating. Resistant and GFP-positive clonal cells were expanded and screened for homogenous GFP expression by flow cytometry.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!